LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production
Authors
Keywords
System lupus erythematosus, Leucine-rich repeat kinase 2, Lupus-like mouse model, B cell differentiation, Antibody production
Journal
Journal of Translational Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-23
DOI
10.1186/s12967-019-1786-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2G2019S-Parkinson’s disease
- (2018) Diana Luz Juárez-Flores et al. Journal of Translational Medicine
- Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association
- (2018) Solana Alculumbre et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Type I Interferons, Autophagy and Host Metabolism in Leprosy
- (2018) Thiago Gomes Toledo Pinto et al. Frontiers in Immunology
- Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus
- (2018) Susan Malkiel et al. Frontiers in Immunology
- LRRK2 promotes the activation of NLRC4 inflammasome duringSalmonellaTyphimurium infection
- (2017) Weiwei Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Peripheral CD19hi B cells exhibit activated phenotype and functionality in promoting IgG and IgM production in human autoimmune diseases
- (2017) Zhicui Liu et al. Scientific Reports
- Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses
- (2016) Makoto Kubo et al. JOURNAL OF NEUROIMMUNOLOGY
- Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway
- (2016) Hong-Ki Min et al. Journal of Translational Medicine
- LRRK2 dephosphorylation increases its ubiquitination
- (2015) Jing Zhao et al. BIOCHEMICAL JOURNAL
- Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
- (2015) João P. L. Daher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Commensal bacteria direct selective cargo sorting to promote symbiosis
- (2015) Qin Zhang et al. NATURE IMMUNOLOGY
- Alternative to LRRK2-IN-1 for Pharmacological Studies of Parkinson's Disease
- (2015) Kyoko Koshibu et al. PHARMACOLOGY
- Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis
- (2015) Hannah Beckwith et al. NEPHRON CLINICAL PRACTICE
- Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China
- (2014) D Wang et al. GENES AND IMMUNITY
- Genetic susceptibility to SLE: Recent progress from GWAS
- (2013) Yong Cui et al. JOURNAL OF AUTOIMMUNITY
- Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations inLRRK2
- (2013) Javier Ruiz-Martínez et al. MOVEMENT DISORDERS
- The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease
- (2013) Hardy J. Rideout et al. NEUROCHEMICAL RESEARCH
- GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
- (2012) Alastair D. Reith et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The role of LRRK2 in inflammatory bowel disease
- (2012) Zhihua Liu et al. CELL RESEARCH
- Germinal center selection and the development of memory B and plasma cells
- (2012) Mark J. Shlomchik et al. IMMUNOLOGICAL REVIEWS
- Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons
- (2011) Nigel Ramsden et al. ACS Chemical Biology
- Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus
- (2011) Sebastian Dolff et al. CLINICAL IMMUNOLOGY
- The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
- (2011) Zhihua Liu et al. NATURE IMMUNOLOGY
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of B cell autoimmunity in SLE
- (2011) Thomas Dörner et al. ARTHRITIS RESEARCH & THERAPY
- Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen
- (2010) Tatsunori Maekawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LRRK2 Is Involved in the IFN- Response and Host Response to Pathogens
- (2010) A. Gardet et al. JOURNAL OF IMMUNOLOGY
- Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
- (2010) R Martínez et al. Journal of Translational Medicine
- Emerging roles of TLR7 and TLR9 in murine SLE
- (2009) Marie-Laure Santiago-Raber et al. JOURNAL OF AUTOIMMUNITY
- The complement system in systemic autoimmune disease
- (2009) Min Chen et al. JOURNAL OF AUTOIMMUNITY
- Induction of autoimmunity by pristane and other naturally occurring hydrocarbons
- (2009) Westley H. Reeves et al. TRENDS IN IMMUNOLOGY
- A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE
- (2008) Matilda W. Nicholas et al. CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started